Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Leuk Res ; 79: 69-74, 2019 04.
Article in English | MEDLINE | ID: mdl-30773246

ABSTRACT

BACKGROUND: Flow cytometry (FC) is a valuable tool for the diagnosis of myelodysplastic syndromes (MDS). We present results of a survey carried out to evaluate FC current practice for MDS diagnosis in Latin America (LA), focusing on markers used and characteristics of the clinical diagnostic report. Compliance to IMDSflow recommendations was also evaluated. These practices were then compared with those used in other countries. METHODS: An online survey was sent through the Grupo Latino-Americano de Mielodisplasia to LA cytometrists and other international scientific societies. RESULTS: 91 responses from 15 LA countries were received. The median of the number of markers used was 20 ± 4.5, but only 8.1% of participants adopted the complete panel proposed by the International/European LeukemiaNet Working Group (IMDSflow). We received 140 eligible answers from regions other than LA (66 Europe, 59 USA-Canada, 8 Oceania, 6 Asia and 1 Africa). LA utilized more markers for MDS diagnosis than USA/Canada (p = 0.006), but similar to Europe. The use of MDS scoring systems differed among regions: 10.3% in LA, 0% USA/Canada and 25.7% Europe reported the "Ogata score". Finally, 52.0% of all participants included a general interpretation statement in the final report about the consistency of the FC results with MDS diagnosis, with no statistical differences between regions. CONCLUSIONS: This survey shows a low compliance with the IMDSflow recommendations and a scarce use of the scoring systems proposed in the literature. However, the number of surface markers used is high. We will work to develop a FC consensus for MDS diagnosis adapted to the clinical practice requirements in LA.


Subject(s)
Flow Cytometry , Myelodysplastic Syndromes/diagnosis , Practice Patterns, Physicians'/statistics & numerical data , Africa/epidemiology , Asia/epidemiology , Biomarkers/analysis , Biomarkers/blood , Canada/epidemiology , Europe/epidemiology , Geography , Humans , Immunophenotyping/methods , Latin America/epidemiology , Myelodysplastic Syndromes/blood , Myelodysplastic Syndromes/epidemiology , Oceania/epidemiology , Surveys and Questionnaires , United States/epidemiology
2.
J Cell Physiol ; 189(2): 121-32, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11598897

ABSTRACT

Cadherins constitute a superfamily of cell adhesion molecules involved in cell-cell interaction, histogenesis and cellular transformation. They have been implicated in the development of various lineages, including derivatives of the neural crest. Neural crest cells (NCC) emerge from the dorsal part of the neural tube after an epithelio-mesenchymal transition (EMT) and migrate through the embryo. After homing and differentiation, NCC give rise to many cell types, such as neurons, Schwann cells and melanocytes. During these steps, the pattern of expression of the various cadherins studied is very dynamic. Cadherins also display plasticity of expression during the transformation of neural crest cell derivatives. Here, we review the pattern of expression and the role of the main cadherins involved in the development and transformation of neural crest cell derivatives.


Subject(s)
Cadherins/physiology , Cell Transformation, Neoplastic , Neural Crest/embryology , Neural Crest/physiology , Animals , Cell Differentiation , Cell Movement , Chick Embryo , Gene Expression Regulation, Developmental , Gene Expression Regulation, Neoplastic , Humans , Melanoma/etiology , Melanoma/genetics , Melanoma/metabolism , Mice , Models, Biological , Neural Crest/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...